STPG2-AS1

Across TCGA pan-cancer cohorts, STPG2-AS1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated STPG2-AS1 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher STPG2-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated STPG2-AS1 expression acts as an unfavorable survival marker, although some lineages such as ACC and LIHC show a favorable association.

UCEC, LUSC, and SKCM are the cancer types where STPG2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	II,III,IV	0.581	0.782	<.001	90	view →
LUSC	DFS	Median	All	0.330	0.623	<.001	51	view →
SKCM	DFS	Tertile	IV	0.111	0.694	.004	45	view →
ACC	DFS	Median	IV	0.495	0.066	.001	28	view →
SARC	DFS	Tertile	All	0.415	0.640	.006	24	view →
LIHC	OS	Tertile	III,IV	0.832	0.581	.005	21	view →
CHOL	DFS	Quartile	All	0.768	0.293	.032	18	view →
KIRC	DFS	Median	IV	0.515	0.207	<.001	12	view →
THCA	OS	Median	IV	0.566	0.924	.010	11	view →
LGG	OS	Tertile	All	0.713	0.873	<.001	11	view →
STAD	DFS	Tertile	All	0.581	0.689	.027	10	view →
BLCA	OS	Quartile	IV	0.126	0.324	.028	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

STPG2-AS1–UCEC (DFS)

Open the UCEC breakdown →